Impax Asset Management Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,115
Closed -$264K 317
2023
Q4
$264K Sell
1,115
-1,987
-64% -$391K ﹤0.01% 359
2023
Q3
$608K Sell
3,102
-141
-4% -$28.9K ﹤0.01% 313
2023
Q2
$682K Sell
3,243
-39
-1% -$7.76K ﹤0.01% 311
2023
Q1
$662K Buy
3,282
+1,127
+52% +$255K ﹤0.01% 304
2022
Q4
$470K Buy
+2,155
New +$471K ﹤0.01% 323
2022
Q3
Sell
-945
Closed -$202K 397
2022
Q2
$202K Hold
945
﹤0.01% 384
2022
Q1
$268K Sell
945
-5
-0.5% -$1.54K ﹤0.01% 387
2021
Q4
$358K Sell
950
-26
-3% -$10.1K ﹤0.01% 363
2021
Q3
$403K Hold
976
﹤0.01% 342
2021
Q2
$361K Hold
976
﹤0.01% 352
2021
Q1
$283K Buy
+976
New +$271K ﹤0.01% 368

Other funds holding CRL